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SUMMARY
Extracellular RNAs (exRNAs) can be released by numerous cell types in vitro, are often protected 
within vesicles, and can modify recipient cell function. To determine how the composition and 
cellular sources of exRNAs and the extracellular vesicles (EVs) that carry them change in vivo 
during tissue inflammation, we analyzed bronchoalveolar lavage fluid (BALF) from mice before 
and after lung allergen challenge. In the lung, extracellular microRNAs (ex-miRNAs) had a 
composition that was highly correlated with airway-lining epithelium. Using cell type-specific 
membrane tagging and single vesicle flow, we also found that 80% of detected vesicles were of 
epithelial origin. After the induction of allergic airway inflammation, miRNAs selectively 
expressed by immune cells, including miR-223 and miR-142a, increased and hematopoietic-cell-
derived EVs also increased >2-fold. These data demonstrate that infiltrating immune cells release 
ex-miRNAs and EVs in inflamed tissues to alter the local extracellular environment.
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Graphical Abstract
In Brief
Using small RNA sequencing and cell type-specific membrane tracing coupled with single vesicle 
flow, Pua et al. demonstrate that immune cell miRNAs and extracellular vesicles increase in 
airway fluid during allergic inflammation. This provides insight into how infiltrating immune cells 
alter the local extracellular environment during tissue immune responses.
INTRODUCTION
Body fluids, including serum/plasma, urine, saliva, bronchoalveolar lining fluid, and 
cerebrospinal fluid, are routine clinical specimens. These biofluids, which are rich in 
metabolites, proteins, and lipids, are also now recognized to carry extracellular nucleic acids, 
including microRNAs (miRNAs). Cellular miRNAs are non-coding ~22 nucleotide RNAs 
that function within cells as post-transcriptional inhibitors of gene expression, modulating 
networks of downstream target genes (Bartel, 2018). Extracellular miRNAs (ex-miRNAs) 
are produced by a wide range of cells and have proposed roles in normal physiology as well 
as disease states (Mateescu et al., 2017). They can be transferred between cells, including 
cells of the immune system (Alexander et al., 2015; Momen-Heravi et al., 2015; Montecalvo 
et al., 2012). The export of miRNAs can be selective (Cha et al., 2015; Santangelo et al., 
2016; Shurtleff et al., 2017; Villarroya-Beltri et al., 2013), and recent studies provide 
experimental evidence that miRNA transfer may affect target cell behavior in immunologic 
processes in vivo, including sepsis (Alexander et al., 2015) and atherosclerosis (Li et al., 
2015).
In body fluids, ex-miRNAs have been most extensively studied within the fluid compartment 
of the blood (serum and plasma). Ex-miRNAs in the blood are stably packaged, occurring in 
extracellular vesicles (EVs) (Hunter et al., 2008), in protein complexes (Arroyo et al., 2011), 
and/or in association with lipoprotein particles (Vickers et al., 2011). They are apparently 
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derived from circulating hematopoietic cells (Pritchard et al., 2012) and from tissues such as 
the placenta during pregnancy (Williams et al., 2013) and adipose tissue (Thomou et al., 
2017). A distinct set of ex-miRNAs has also been identified as being associated with the 
respiratory tract in induced sputum and bronchoalveolar lavage fluid (BALF) (Maes et al., 
2016; Seumois et al., 2012), as well as the EV-enriched 100,000 g pelleted fraction from 
BALF (Levänen et al., 2013). However, for disease processes in the lung, many fundamental 
questions remain to be answered. Determining the cellular sources and composition of EVs 
and exRNAs in vivo are essential first steps in understanding their function in pathologic 
processes in this organ. Additional work on exRNA packaging and target cell delivery will 
be necessary to harness their clinical potential.
In the present study, we show that ex-miRNAs are abundant in airway lining fluid (as 
measured through bronchoalveolar washes), but they have a composition that is distinct from 
that of serum. We find that the miRNA composition of BALF largely mirrors that of the 
local tissue, in particular, the mucosal epithelium lining the airways. We demonstrate that 
EVs are present within BALF and that ex-miRNAs are associated with vesicleenriched 
fractions. Coupling a membrane fluorescent protein reporter system with EV flow, we 
characterize the sources and heterogeneity of EVs in the lung. Finally, we identify increases 
in ex-miRNAs selectively expressed as intracellular miRNAs in hematopoietic cells and a 
corresponding increase in the number of hematopoietic cell-derived EVs in a mouse model 
of allergic airway disease.
RESULTS
Abundant Ex-miRNAs in Airway Lining Fluid
To determine the composition of ex-miRNAs in the airways, BALF was collected as a single 
1-mL wash from mice. miRNA sequencing libraries were generated from cell-free BALF 
based on previous literature with minor modifications (Williams et al., 2013), and the data 
were processed using the exceRpt small RNA-sequencing (RNA-seq) pipeline for alignment, 
annotation, and counting (http://www.genboree.org/site/, developed by the Data Integration 
and Analysis Component of the Extracellular RNA Communication Consortium). 
Modification to the published sequencing protocol included the addition of 5 random 
nucleotides at the ligating ends of both the 5′ and 3′ adapters. Addition of random 
nucleotides can reduce ligation bias, which is particularly problematic with short invariant 
sequences such as miRNAs (Jayaprakash et al., 2011; Zhuang et al., 2012).
In addition to BALF, 3 more specimens were collected and submitted for sequencing (Figure 
1A). Serum was collected and sequenced as a second biofluid containing ex-miRNAs. We 
also sequenced miRNAs from the cellular sources we hypothesized as being the most likely 
to contribute to BALF ex-miRNAs: lung epithelial cells and hematopoietic cells in the 
airways. Bronchial epithelial cells were collected from airway brushings, and hematopoietic 
cells from the airways were collected as 300-g cellular pellets from BALF washes. An 
average of 550,000 miRNA reads were obtained from each sample (Table S1). In most 
cases, miRNAs constituted >80% (range, 69%–95%) of all mapped sequencing reads, with 
the remainder of the reads being composed predominantly of mRNA (average of 5%), rRNA 
(average of 4%), and tRNA (average of 3%) fragments. Circular RNAs and PIWI-interacting 
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RNAs (piRNAs) each accounted for <0.5% of the total aligned reads. Overall, no striking 
qualitative differences in the distribution of small RNA types were observed between the 
sequenced samples (Figure 1B).
During library preparation, a mixture of 5 calibrator sequences were spiked into the ligation 
reaction at a known concentration. These calibrators are miRNA-like synthetic 
oligoribonucleotides with 5′-monophosphates and no matches to the mouse genome 
(Williams et al., 2013). The total number of miRNA reads from each sample could then be 
estimated as a molar concentration of miRNAs sequenced per input of total RNA using 
mapped calibrator reads (Figure S1). In BALF, epithelial brushings and hematopoietic cell-
rich pellets on the order of 10 fmol of miRNAs were sequenced per microgram of input total 
RNA (Figure 1C). This was significantly less than the amount that was sequenced from 
serum, which averaged closer to 100 fmol of miRNAs per microgram of input total RNA. 
Bioanalyzer tracings of total RNA isolated from both biofluids showed similar size 
distributions and a predominance of small RNA species (Figure S2). In contrast, cellular 
RNA contained intact large ribosomal RNA subunits. Therefore, despite the similar miRNA 
content per microgram of total RNA in BALF and cellular samples, these data indicate that 
BALF contains little or no intact cellular RNA. Rather, it suggests that blood and airway 
biofluids may contain different relative amounts of other small RNAs or RNA fragments that 
were not sequenced by this library preparation protocol.
Using our calibrators and average input volumes for RNA purification, we also calculated 
the number of ex-miRNAs per unit volume in the 2 biofluids examined. We calculate an 
average of 3 million total miRNAs per microliter of BALF and 8 million total miRNAs per 
microliter of serum (Figure 1D). Estimates of the volume of epithelial lining fluid in the lung 
suggest that the process of bronchoalveolar lavage dilutes this biofluid 10- to 100- fold 
(Dargaville et al., 1999; Rennard et al., 1986). Therefore, it seems likely that on a per-
volume basis, the airway lining fluid has at least as many miRNAs as the blood.
A relatively small number of unique miRNAs contributed the majority of sequenced reads in 
the miRNAome of each specimen type (Figure 1E). The most highly expressed miRNA in 
each specimen type (miR-21a-5p in BALF and epithelial brushings, and miR-451a in serum 
and pellet) constituted 15%–41% of all reads, and the top 30 miRNAs made up 76%–83% of 
all of the reads sequenced. Thus, although sequenced reads mapped to >400 individual 
annotated miRNAs in all of the samples, there were a limited number of abundant miRNAs 
in both body fluids and cells.
Epithelial Cell miRNAs Dominate BALF Ex-miRNA Composition in Lungs
Principal-component analysis of the top 100 most variant miRNAs showed strong clustering 
of individual samples by specimen type (Figure 1F). Three clearly distinct clusters emerged 
from this analysis: a serum cluster, a hematopoietic cell-rich pellet cluster, and a mixed 
BALF and epithelial brushing cluster. Principal-component 1, which accounted for 64% of 
variance, separated serum from all of the other specimen types. Principal-component 2, 
which accounted for 17% of variance, separated the cell pellet from the mixed BALF and 
epithelial group. Consistent with the principal-component analysis, BALF and epithelial 
brushings had the strongest correlation coefficients (Pearson’s r = 0.97) when the top 200 
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most abundant miRNAs were used for comparison (Figure S3). The BALF ex-miRNA 
profile was much more poorly correlated with that of serum (Pearson’s r = 0.52) and 
intermediately correlated with miRNAs in the hematopoietic cell-rich pellets from bronchial 
washings (Pearson’s r = 0.72). This analysis shows that miRNAs expressed in BALF are 
more similar to cells present in and lining the airways than the other biofluid sequenced in 
this study—serum.
To visualize the absolute expression of the most abundant miRNAs sequenced, clustering 
was performed for only the top 50 expressed miRNAs from each specimen type. Based on 
cumulative frequency calculations (Figure 1E), this constituted ≥80% of the total reads 
sequenced in each sample. After supervising the clustering of samples by specimen type, 
unsupervised hierarchical clustering of miRNAs was performed using calibrator normalized 
attomols of miRNA per microgram of input total RNA. Among all of the specimen types, 
there were shared abundant (group 1), intermediate (group 4), and lower (group 6) expressed 
groups of miRNAs. Notable among these shared abundant miRNAs (group 1) were 
miR-21a-5p, all 3 members of the Mirc11 cluster of miRNAs (miR-23a, miR-27a, and 
miR-24-3p), miR-22-3p, and miR-29a-3p (Figure 1G). There were also 2 miRNAs known to 
be highly expressed in red blood cells that were the most abundant in serum, miR-451a and 
miR-16-5p. Visual inspection of the heatmap showed a coordinated intensity of miR-451a, 
miR-16-5p, and miR144-3p within select individual samples, and likely represents a 
signature of red blood cell lysis (Kirschner et al., 2011; Pritchard et al., 2012).
This analysis also highlighted a subset of miRNAs that were present at roughly equivalent 
levels in BALF and epithelial brushings, but were absent (group 2) to low (group 5) in both 
serum and hematopoietic cell-rich bronchoalveolar lavage cell pellets (Figure 1G). Notable 
among these were multiple members of the miR-34/449 family of miRNAs, which are 
highly expressed in ciliated epithelium, including lung epithelium, and are required for 
proper cilia formation and function (Marcet et al., 2011; Song et al., 2014). Multiple 
members of the miR-141/200/429 family were also present in this group. These miRNAs are 
highly expressed in the lung (Hasuwa et al., 2013), and deficiency of some family members 
such as miR-200b result in altered lung function in the mouse (Khoshgoo et al., 2017). 
Similarly, there was a group of miRNAs that were more highly abundant in serum and/or 
hematopoietic cell-rich pellets than in BALF or epithelial brushings (group 7). Included 
among these were miRNAs with preferential expression in the immune system and roles in 
immune cell differentiation and function (Chen et al., 2004; Landgraf et al., 2007; Monticelli 
et al., 2005). For example, miR-150-5p and miR-142a both are important for lymphocyte 
development (Kramer et al., 2015; Xiao et al., 2007), and miR-223 regulates myeloid cell 
differentiation and activation (Johnnidis et al., 2008). These data indicate that airway 
epithelial cells are by far the greatest contributor to the abundant ex-miRNA pool present in 
the airway lining fluid of lungs.
Ex-miRNAs in the BALF Are Protected from Degradation
Free RNA molecules are notoriously unstable due to the ubiquity of RNases that induce their 
rapid degradation. In blood, endogenous ex-miRNAs have been shown to be surprisingly 
stable (Arroyo et al., 2011). To test whether endogenously produced ex-miRNAs in the 
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BALF are protected from degradation, RNA spike in experiments were performed. 
Calibrators from miRNA sequencing were once again used, this time to test the stability of 
naked RNAs in BALF. When 60 million copies of calibrator 1 and 600,000 copies of 
calibrator 2 were spiked into 200 μL BALF after the addition of Trizol in preparation for 
RNA extraction, these calibrators could be detected at 24 and 31 cycles, respectively, in 
quantitative RT-PCR analyses (Figure 2A). However, when these calibrators were spiked 
into BALF and incubated for 5 min at 37°C before the addition of Trizol reagent, both were 
undetectable. The pre-addition of an RNase inhibitor significantly protected these synthetic 
miRNAs from degradation. These data show that endogenous ex-miRNAs are stabilized in 
epithelial lining fluid in the lung and protected from the activity of endogenous RNases. 
RNases have been documented in the BALF and may arise in part from alveolar 
macrophages located there (Cormier et al., 2002).
To confirm the stability of ex-miRNAs present in lung lining fluid, freshly isolated BALF 
from mice was obtained and incubated with additional RNase A. Two highly abundant 
miRNAs, miR-21a-5p and miR-24-3p, were protected from RNase A degradation in the 
BALF when compared to RNA previously extracted from the same BALF (Figure 2B). This 
was also true for miRNAs in the BALF that were preferentially expressed in the serum and 
inflammatory cell pellet (miR-223-3p) or in epithelial cells (miR-34c-5p), as well as for 
5.8SrRNA (Figure 2B). In all of the cases, these RNAs were rapidly degraded when RNase 
A was added to RNA previously extracted from the BALF. These data confirm that ex-
miRNAs in the BALF are present in a protected form.
EVs Are Present in the BALF
Given the stability of miRNAs in the BALF, we hypothesized that EVs present in lung lining 
fluid may carry miRNAs. To characterize EVs present in the lung, nanoparticle tracking was 
performed. On the order of 108 particles were present per microliter of this diluted biofluid. 
Although not statistically significantly different due to a single high outlier among the tested 
serum samples, the median number of particles in serum appeared to be higher, at close to 
109 particles per microliter (Figure 3A). Nanoparticle tracking allows the assessment of 
particle size in addition to concentration. The size distribution of particles in the BALF was 
larger than that seen in the serum, with a mode of ~125 nm in BALF and ~90 nm in serum 
(Figure 3B). These results show that abundant sub-200-nm particles are present in both 
biofluids, which is consistent with the presence of small EVs.
To visualize EVs present in the BALF, we performed transmission electron microscopy of 
negatively stained 100,000 g BALF pellets that had been pre-cleared of debris, as well as 
largersized EVs and aggregates by prior serial centrifugation at 1,200 and 10,000 × g. We 
observed 2 discrete populations of vesicles. By morphology, ~90% of the vesicles appeared 
liposome-like with a uniform electron density, variable size, and irregular cell border 
(Figures 3C and 3D). These structures are interpreted to be derived from the disruption of 
the surfactant lipid monolayer lining the lung during the process of lavage. In contrast, just 
under 10% of the vesicles had a morphology that was consistent with that of EVs. This 
second group of vesicles had a donut-shaped appearance of electron density with proteins 
visibly studding the surface and an average size of ~100 nm diameter (99 nm median, 108 
Pua et al. Page 6
Cell Rep. Author manuscript; available in PMC 2019 February 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
nm mean) (Figures 3C–3E). These EV particles share similarities in morphologies to 
exosome-like vesicles present in human plasma (Caby et al., 2005).
To determine whether EVs present in the BALF express EV-associated protein markers, 
western blots of 100,000 g pellets were performed after differential centrifugation. BALF 
from this pelleted fraction contained EV membrane organizers, including CD9 and CD63, as 
well as proteins associated with EV biogenesis, including Alix, Tsg101, Syntenin, and Arf6 
(Figure 3F). When equal total protein was loaded, markers were more highly enriched in 
100,000 g BALF pellets than lysates either collected from hematopoietic cells in the airway 
or 100,000 g pellets collected from serum. However, when equal numbers of particles from 
BALF and serum 100,000 g pellets were compared, EV markers were more highly expressed 
in the serum (Figure 3G). These differences suggest that EVs present in these 2 biofluids 
exist amid different compositions of free proteins and lipid particles in airways and the 
circulation. In summary, data from nanoparticle tracking, electron microscopy, and western 
blot analysis demonstrate that among particles recovered from cell-free BALF, small EVs 
are present.
Select Ex-miRNAs Are Changed in the BALF during Allergic Inflammation
Asthma is a prevalent disease that affects >8% of the US population (Moorman et al., 2012) 
and causes dramatic changes in the lungs of affected individuals. In the Th2-high endotype 
of asthma, these changes include the recruitment of a mixed type 2 inflammatory infiltrate 
with eosinophils to the lung parenchyma and bronchoalveolar space, as well as metaplasia of 
bronchial epithelium and stromal remodeling (Fahy, 2015). Given these changes in cell 
composition and cell function, we hypothesized that ex-miRNAs present in the lung lining 
fluid would change during asthmatic inflammation. To model allergic-type asthmatic 
responses with recruitment of type 2 inflammatory cells to the lung, we used an antigen 
sensitization and challenge model. Mice were sensitized to the model antigen ovalbumin 
(OVA) via intraperitoneal immunization with the adjuvant alum and then challenged by 
aspiration of OVA. We and others have shown that after 3 days of OVA challenge, a robust 
type 2 immune response is induced in the lungs with recruitment of Th2 cells and 
eosinophils to the airways and mucus metaplasia of bronchial epithelium (Nials and Uddin, 
2008; Pua et al., 2016).
The miRNA sequencing performed on each specimen type (see Figure 1) included samples 
from 3 experimental groups (Figure 4A). One cohort of mice (CTR) was neither sensitized 
by intraperitoneal injection nor challenged in the lung. One cohort of mice (IMM) was 
immunized intraperitoneally with OVA and alum but challenged in the lung with PBS only. 
The last cohort of mice (AA) was immunized with both OVA and alum intraperitoneally and 
then challenged in the lung with OVA to recruit a local type 2 lung inflammatory response. 
When the calibrator-calculated amount of total miRNAs sequenced was compared between 
CTR, IMM, and AA mice for each sample type, no statistically significant difference in the 
miRNA content was observed (Figure 4B). In addition, no differences in the concentration 
of ex-miRNAs per volume of biofluid were detected in BALF between the 3 experiment 
groups, and there was overall only a trend toward slightly increased ex-miRNA in the serum 
of IMM or AA mice when compared with CTR (Figure 4C).
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However, allergic airway inflammation induced major changes in the abundance of specific 
miRNAs in airway-lining fluid. To identify changed miRNAs after the induction of a type 2 
inflammatory response in the lungs, differential expression analysis was performed to 
compare the BALF of AA to CTR and IMM mice (Table S2). Since no differentially 
expressed miRNAs were observed between IMM and CTR BALF (Table S3), these samples 
were grouped for comparison to AA samples. A total of 12 miRNAs were upregulated in the 
BALF of mice with allergic airway inflammation having high statistical significance (padj < 
0.001) (Figure 4D; Table S4). Among the most abundant of these miRNAs were miR-223-3p 
and miR-142a (both 5p and 3p). Since these miRNAs are highly and preferentially expressed 
in hematopoietic cells (Chen et al., 2004; Landgraf et al., 2007; Monticelli et al., 2005), we 
next performed a differential expression analysis between hematopoietic cell pellets and 
epithelial brushings collected from AA mice. Almost all of the miRNAs upregulated in AA 
BALF were also preferentially expressed in hematopoietic cell pellets relative to epithelial 
brushings (Figure 4E; Table S4).
Not all of the abundant miRNAs preferentially expressed in hematopoietic cell-rich pellets 
were increased in AA BALF. Notable among those absent from the list were miR-150-5p 
(log2 fold change AA versus CTR/IMM BALF = 0.9, padj = 0.16), miR-146b-5p (log2 fold 
change AA versus CTR/IMM BALF = −0.3, padj = 0.65), and miR-342-3p (log2 fold 
change AA versus CTR/IMM BALF = −0.4, padj = 0.64). This is particularly striking for 
miR-150, as prior studies have shown that lymphocyte activation is associated with 
decreased cellular levels of select miRNAs, including miR-150, with accumulation in 
exosomes, and correlates with enhanced extracellular levels in serum after immunization in 
mice and humans (de Candia et al., 2013). To determine whether increases in select ex-
miRNAs in the allergic lung may result from sequence-specific secretion, we performed 
motif analysis. Although sequence-specific trafficking of miRNAs into EVs has been 
documented in immune cells (Villarroya-Beltri et al., 2013), we did not identify significantly 
enriched motifs among ex-miRNAs upregulated in AA BALF. These data suggest that 
upregulation of select ex-miRNAs in AA BALF may result from differences in the immune 
cell populations present and/or export mechanism that depend on proteins but are 
independent of primary miRNA sequence, as has been suggested for miR-223 and the RNA 
binding protein YBX1 (Shurtleff et al., 2016). Overall, our findings support the hypothesis 
that the influx of inflammatory cells during an allergic response contribute a select 
subpopulation of ex-miRNAs in the airways.
To determine whether ex-miRNAs selectively expressed in hematopoietic cells and increased 
in allergic airways were present in vesicle-enriched fractions, we performed a qPCR analysis 
of 100,000 g pellets that were floated into sucrose density gradients. Prior work has 
demonstrated that in a 20%/40%/60% sucrose gradient, EVs will be enriched at the interface 
of the 20% and 40% fractions (Shurtleff et al., 2016). Across all of the miRNAs tested, we 
saw the fewest ex-miRNAs in the 20% fraction (Figure 4F). When fractions were compared 
between experimental groups, no differences in the amounts of miR-21a-5p or miR-34c-5p 
were found between IMM and AA mice (Figure 4F). These data are consistent with 
differential expression analyses of RNA-seq data, in which no difference was observed in 
these abundant miRNAs between groups. In contrast, ex-miRNAs whose expression was 
increased in AA BALF were also increased by qPCR analysis. Differences of 3–4 cycles 
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(estimated 6- to 8-fold) were seen across all of the fractions collected. Of note, the amount 
of other small RNA species (e.g., 5.8S rRNA and U7 small nuclear RNA [snRNA]) was 
largely unchanged between fractions and after the induction of allergic airway inflammation 
(Figure 4F). These data support the hypothesis that a subset of EV-packaged miRNAs are 
upregulated during allergic airway inflammation.
EV Flow with Conditionally Expressed Membrane Fluorescent Proteins
Pioneering work on EV flow has enabled the measurement of single vesicles from complex 
biofluids. This has allowed for the characterization of EV size and surface markers 
expression (Higginbotham et al., 2016; Inglis et al., 2015; Morales-Kastresana et al., 2017; 
Nolte-’t Hoen et al., 2013; Stoner et al., 2016). Given our data showing that hematopoietic 
miRNAs increase in the BALF with allergic inflammation, we combined a lineage-specific 
fluorescent labeling system with flow analysis to trace the origin of EVs in our mouse model 
of asthma. We used a CytoFLEX flow cytometer (Beckman Coulter), which was optimized 
for the detection of EVs and could detect beads down to 100 nm (Figure 5A), and we 
obtained transgenic mice that express membrane-anchored fluorescent proteins. These mice 
(hereafter referred to as mTmG mice) express a membrane-bound tandem dimer Tomato 
(mT) that is genetically replaced with membrane-bound GFP (mGFP) in cells expressing 
Cre recombinase (Muzumdar et al., 2007). EV flow of BALF collected from mTmG mice 
showed the presence of red Tomato+ EVs (Figure 5B). When mTmG mice were crossed with 
the ubiquitously expressed Actin-Cre transgene, all of the fluorescent EVs detected in the 
BALF were green and not red. The number of fluorescent EVs detected after a single 1-mL 
BAL wash in each mouse was on the order of 105 vesicles/μL (Figure 5C). Using beads to 
calculate a linear regression of violet side scatter (SSC) to bead size, the median vesicle size 
detected in both was equivalent (Figure 5D). EV flow was also performed on serum; 
however, no reliable mT signal could be detected above background (Figure S4A). 
Nevertheless, these results permit single vesicle analysis of BALF EVs using membrane-
associated fluorescent proteins expressed in the cells of origin.
Inflammatory Cell-Derived Airway EVs Increase with Allergic Inflammation
Given the strong correlation between the miRNA profiles of epithelial cell brushings and the 
BALF, we wanted to determine the relative contribution of epithelial and hematopoietic cells 
to the EV pool in this biofluid. To specifically label lung epithelial cells with membrane-
targeted GFP, mTmG mice were crossed to Nkx2.1-Cre mice (Xu et al., 2008). This 
transgene exhibits expression in the lung epithelium as well as the thyroid, pituitary, and 
subdomains of the brain, but not in immune cells or other structural cells in the lung. To 
specifically label immune cells, the mTmG line was also crossed to the pan-hematopoietic 
expressed Vav-Cre line (de Boer et al., 2003). Fluorescent microscopy of lung sections 
demonstrated mG labeling of bronchial and alveolar epithelium in mTmG Nkx2.1-Cre and 
alveolar macrophage and scattered hematopoietic cell labeling in mTmG Vav-Cre mice, as 
expected (Figure 6A).
EV flow analysis of BALF showed that ~80% of fluorescent positive EVs in mTmG 
Nkx2.1-Cre mice were mG+ and therefore of epithelial origin in the lung (Figure 6B). No 
mG+ EVs were detected above baseline in the serum of these mice (Figure S4B). In BALF 
Pua et al. Page 9
Cell Rep. Author manuscript; available in PMC 2019 February 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
from mTmG Vav-Cre mice, ~15% of EVs detected by EV flow were of hematopoietic cell 
origin (Figure 6B). In contrast, the vast majority of EVs detected in the serum were of 
hematopoietic origin (Figure S4B). Overall, we could visualize on the order of 100 million 
fluorescent positive epithelial and 10 million fluorescent positive hematopoietic-derived EVs 
in a 1-mL BALF wash (Figure 6C). No difference in the median size of epithelial or 
hematopoietic EVs was identified (Figure 6D).
To determine whether there was a change in epithelial or hematopoietic origin EVs in the 
setting of a local type 2 inflammatory response in the lung, EV flow was performed on 
BALF from IMM and AA mTmG Nkx2.1-Cre and mTmG Vav-Cre mice. The total number 
and mode of the diameter of EVs detected in the BALF by nanoparticle tracking was 
unchanged in mice with allergic airway inflammation (Figure S5). However, mTmG Vav-
Cre mice did exhibit a statistically significant increase in the percentage of mG+ 
hematopoietic-derived EVs among all of the fluorescent positive EVs, from 13% in IMM 
mice to 21% in AA mice (Figures 6E and 6F). This correlated with a 2.7-fold (range, 1.5- to 
5.1-fold) increase in the absolute number of hematopoietic-derived EVs during allergic 
inflammation (Figure 6G). There was also a trend toward increased epithelial EVs in mTmG 
Nkx2.1-Cre in the inflamed lung; however, this did not achieve statistical significance, and 
no difference in the percentage of mG+ EVs in these mice was observed. Our data indicate 
that airway inflammation increases the contribution of infiltrating immune cells to airway-
lining fluid EVs and ex-miRNAs.
DISCUSSION
Body fluids harbor a surprisingly high concentration of small exRNAs stabilized in 
association with EVs. Active secretion of EVs and ex-miRNAs may influence the function 
of both source and recipient cells and provides an opportunity for biomarker discovery in 
accessible biospecimens. In this study, we set out to determine how the composition and 
cellular sources of ex-miRNAs and the EVs that carry them change during tissue 
inflammation. Studying allergic lung inflammation using mouse models of asthma, we 
found that hematopoietic miRNAs and vesicles specifically increased in BALF. This 
occurred in the context of a biofluid that contained predominantly epithelial ex-miRNAs and 
EVs arising from the most abundant cells lining the airways. These findings matched our 
expectation that immune cell secretion of RNA and vesicles into the extracellular space will 
alter the local tissue environment and the biofluids associated with it.
In our studies, we performed both qualitative and quantitative studies of ex-miRNAs and 
EVs in BALF. Although our EV flow cytometry studies successfully discriminated EVs of 
epithelial and immune cell origin, the total number of particles detected using this method 
was substantially lower than the number counted by nanoparticle tracking assays (0.1% on 
average). This likely reflects a combination of limitations in the detection of small and dimly 
fluorescent vesicles by EV flow cytometry, and highlights both the need for and great 
potential of continued technical innovation in the field. Still, our work allows us to begin to 
address important quantitative questions such as how many molecules of RNA are packed 
into an individual EV in vivo. For both BALF and serum, we detected ~50–100 times more 
EV-sized particles by nanoparticle tracking than ex-miRNAs per microliter of fluid. Studies 
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on purified EVs isolated from glioma stem cell cultures have estimated approximately 1 
miRNA per EV generated in conditioned media in vitro (Wei et al., 2017). These results 
suggest that BALF is likely to contain a subpopulation of EVs that carry ex-miRNAs, which 
is not an altogether surprising finding given that BALF contains a complex mixture of 
surfactant, proteins, and EVs from different cellular sources. Important and difficult-to-
address questions remain as to the number and distribution of RNA within heterogeneous 
populations of individual EVs, particularly in vivo.
While our results supported our overall hypothesis that miRNAs and EVs would change 
with mouse models of asthma, there were a number of surprising findings. We did not 
identify striking changes in any epithelial miRNAs, despite a prior study identifying the 
downregulation of miR-34/449 and miR-141/200/429 families in EV-enriched fractions from 
asthmatic patients that predicted lung function (Levänen et al., 2013). Perhaps the 
investigation of mouse models that better mimic a mild, chronic form of the disease will 
identify a role for epithelial EVs and/or ex-miRNAs in defining and contributing 
mechanistically to disease pathogenesis. Also of interest was the fact that although the 
induction of systemic inflammation dramatically changed the ex-miRNA profile in serum, 
we could detect neither a specific ex-miRNA signature nor epithelial EVs in circulation in 
AA mice that reflected the induction of local inflammation in the lung. It will be interesting 
to determine whether inflammation induced in and restricted to the lung can produce a 
detectible inflammatory signal in the circulation.
Perhaps some of the most exciting long-term questions raised by this work are what may be 
the functional consequences of alterations in ex-miRNAs and EVs derived from different 
cell sources in vivo in pathologic inflammation. Two of the ex-miRNAs identified as 
upregulated in allergic BALF may be particularly attractive for future study, as both 
miR-223-3p and miR-142a-3p are upregulated in the sputum of patients with a severe form 
of the neutrophilic subtype of asthma, and their levels correlate with disease severity (Maes 
et al., 2016). miR-223 is highly expressed in myeloid linage cells and limits neutrophil 
production, maturation, and activation (Johnnidis et al., 2008). This function is particularly 
important in the lung, as mice deficient in this miRNA develop spontaneous lung 
inflammation and have enhanced susceptibility to acute lung injury (Johnnidis et al., 2008; 
Neudecker et al., 2017). miR-142 contributes to the development and function of multiple 
hematopoietic cell subsets, including megakaryocytes, dendritic cells, mast cells, and 
lymphocytes (Chapnik et al., 2014; Kramer et al., 2015; Mildner et al., 2013; Yamada et al., 
2014). In addition, interleukin-4 (IL-4) and IL-13 can induce mir-142a in macrophages to 
promote a profibrogenic pathway in the lung (Su et al., 2015). Studying the sources and 
function of these 2 ex-miRNAs may contribute to our understanding of asthma, especially 
given that extracellular miR-223 can be transferred to lung epithelial cells in vitro 
(Neudecker et al., 2017).
In this study, we set out to begin to answer a number of fundamental questions about ex-
miRNAs and EVs in airway-lining fluid. Our findings allowed us to assign cellular sources 
in both healthy lungs and lungs with allergic airway inflammation. They also highlight that 
changes in extracellular fluids reflect changes in the composition and/or function of cells in 
the environment during local tissue inflammation. Our study sits amid an emerging literature 
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on the biogenesis and delivery of exRNA (Patton et al., 2015) and the EVs that can carry 
them (Tkach and Tháry, 2016). It is a field that holds promise for the discovery of basic 
principles of cell biology and molecular physiology, as well as strategies that can be 
leveraged for diagnostic and therapeutic advancement.
STAR★METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Mark Ansel (mark.ansel@ucsf.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice—Wild-type, mTmG, mTmG Actin-Cre, mTmG Vav-Cre, and mTmG Nkx2.1-Cre 
male and female mice were used at greater than 5 weeks of age. mTmG mice (B6.129(Cg)-
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J, RRID:IMSR_JAX:007676) were crossed to 
Actin-Cre mice (B6N.FVB-Tmem163Tg(ACTB-cre)2Mrt/CjDswJ), RRID:IMSR_JAX:019099), 
Vav-Cre mice (B6.Cg-Commd10Tg(Vav1-icre)A2Kio/J, RRID:IMSR_JAX:008610) or Nkx2.1-
Cre mice (C57BL/6J-Tg(Nkx2-1-cre)2Sand/J, RRID:IMSR_JAX:008661, The Jackson 
Laboratory) to generate mice with membrane GFP labeling in all cells, hematopoietic cells 
or lung epithelial cells, respectively. All mice were housed and bred in specific pathogen-
free conditions at the University of California, San Francisco, or at Vanderbilt University 
Medical Center. Animal experiments were approved by the Institutional Animal Care and 
Use Committee of the University of California, San Francisco, or Vanderbilt University 
Medical Center.
METHOD DETAILS
Allergic airways and specimen collection—Bronchoalveolar lavages were performed 
with 1 mL of cold PBS. BAL fluid was centrifuged at 500 g for 5 minutes to separate cell 
free BALF supernatant from hematopoietic cell rich cell pellets. To perform epithelial 
brushings, brushes were made from 60-grit sandpaper–polished polyethylene PE-10 tube 
(BD Biosciences) (Sugimoto et al., 2012). The brush was inserted postmortem through the 
trachea to the mid mediastinum (past the bifurcation of the right and left mainstem 
bronchus). The epithelium was gently brushed and collected cells washed directly into 
Trizol. Blood was drawn slowly from the inferior vena cava immediately postmortem into a 
1 or 3ml syringe using a 23G needle to limit hemolysis and collected into a microtainer 
serum separator tube (Beckton Dickinson). Serum was isolated by centrifugation at 6000 
rpm for 3 minutes, followed by centrifugation at 1200 g for 20 minutes to remove residual 
red blood cells. Visibly hemolyzed specimens were not used for study. For allergic airway 
experiments, mice were injected intraperitoneally weekly for 3-4 weeks with 50 ug 
ovalbumin (OVA, Sigma-Aldrich) in 100 ul of PBS plus 100 ul of Imject alum (Thermo 
Scientific). Starting 7 days after the last injection, mice were challenged daily by 
oropharyngeal aspiration of 50 ug OVA in 20 ul of PBS or 20 ul of PBS alone for three 
consecutive days. Specimens were collected on day 4 after the first lung challenge.
Pua et al. Page 12
Cell Rep. Author manuscript; available in PMC 2019 February 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Small RNA sequencing and data analysis
Total RNA was isolated using Trizol LS (for fluids, Invitrogen) and Trizol (for cell pellets, 
Invitrogen) from 500ul of cell free BALF, bronchoalveolar lavage cell pellets, epithelial 
brushings or ~200ul of serum. Each biologic replicate was obtained from a single mouse, 
except for epithelial brushings, which were pools of 1-3 mice. Total RNA was quantified 
using the RNA 6000 Pico Kit on a Bioanalyzer (Agilent). 20-65ng of total RNA was used 
for small RNA sequencing library generation as previously described (Williams et al., 2013). 
The following modifications were made to the published small RNA sequencing protocol. 
Five random nucleotides were added to the 5′ end of the 3′ oligodeoxynucleotide adaptor 
with the resulting modified adaptor sequence: 5Phos/NNNNNXXXXXTGGA 
ATTCTCGGGTGCCAAGG/3AmMO (where “N” are random nucleotides and “X” are 
pentamer indexing barcodes as outlined in the original protocol). Five random nucleotides 
were also added to the 3′ end of the 5′ oligoribonculeotide adaptor with the resulting 
modified adaptor sequence: 
rGrUrUrCrArGrArGrUrUrCrUrArCrArGrUrCrCrGrArCrGrArUrCrNrNrNrNrN (where 
“rN” are random nucleotides). 3′ adapters were adenylated enzymatically using the 5′ DNA 
Adenylation Kit (New England Biolabs) for 80min at 65oC. Adenylated adapters were 
subsequently ethanol precipitated. A mix of calibrators 1, 2, 3, 4 and 7 were used at a final 
combined concentration of 0.025nM in the 3′ ligation reaction. For RT of the library, the 
following primer was used: GCCTTGGCACCCGAGAATTCCA. The library was amplified 
by qPCR using Phusion High-Fidelity DNA Polymerase (New England Biolabs). The 5′ 
PCR primer was as specified in the original protocol. The 3′ primer used was 
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCCTTGGCACCCGA
GAATTCCA. Amplification was stopped before the reaction reached plateau phase, and the 
product purified by phenol:chloroform extraction. Libraries were sequenced on a HiSeq2500 
(Illumina). Data was demultiplexed and adapters trimmed using FastX Toolkit (http://
hannonlab.cshl.edu/fastx_toolkit/index.html) and cutadapt (Martin, 2011). Sequence 
alignment and small RNA read counts were obtained using the exceRpt small RNA-seq 
Pipeline (v4) (http://www.genboree.org/site/). Comparative expression analysis was 
performed with DESeq2 (Love et al., 2014). Motif analysis of mature miRNA sequences 
upregulated in BALF was performed using DREAM (Discriminative Regular Expression 
Motif Elicitation), (http://meme-suite.org/doc/dreme.html) (Bailey, 2011) using ex-miRNAs 
that were unchanged or downregulated as a control and returned no results with an E-value 
of < 0.05. Motif analysis was also performed using Improbizer (https://users.soe.ucsc.edu/
~kent/improbizer/improbizer.html) with a Markov 0 background model, an initial minimum 
motif size of 4 nucleotides, and randomly generated control data. The significance score for 
the top motif in miRNA sequences upregulated in AA BALF (3.63) was similar to the 
average value obtained in 10 control runs with random sequences (3.67 ± 0.17).
exRNA stability—To test whether synthetic miRNA-like oligoribonucleotide sequences 
were intrinsically stable in BALF, 22 nucleotide RNA calibrators (calibrators 1-4 (Williams 
et al., 2013)) were spiked into BALF and incubated for 5min at 37°C with or without 
RNAsin ribonuclease inhibitor (Promega) before RNA extraction. To test whether 
endogenous ex-miRNAs were stable to exogenous RNases, RNase A (Thermo Scientific) 
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was added to BALF or total RNA previously isolated from BALF at 0.04-40ug/ml and 
incubated for 37°C for 15min before RNA extraction.
qPCR—Total RNA was isolated from fluids using Trizol LS (Invitrogen) and cells or 
vesicle pellets using Trizol (Invitrogen). Small RNA reverse transcription was performed 
using the miR-X First Strand Synthesis kit (Clonetech). Forward primers for miR-21a-5p, 
miR-24-3p, miR-34c-5p, miR-142a-3p, miR-200b-3p, and miR-223-3p were the full mature 
miRNA sequence (www.mirbase.org). Forward primers for other small RNAs included the 
5.8S ribosomal RNA ATCGTAGGCACCGCTACGCCTGTCTG and U7 small nuclear RNA 
GTTACAGCTCTTTTAGAATTTGTCTAGC. The miR-X First Strand Synthesis kit 
(Clonetech) common reverse primer was used for all reactions. qPCR was performed on a 
CFX96 Quantitative PCR Thermocycler (Biorad) or a QuantStudio 3 (Applied Bio-systems) 
in technical duplicate using Roche FastStart Universal SYBR Green Master mix [Rox] 
(Sigma-Aldrich). Technical replicates with > 1 cycle s.d. were excluded from analysis.
Extracellular vesicle fractionation—After BALF was centrifuged at 300-500 g for 10 
minutes to remove cells, fluid was serially centrifuged at 1,200 g for 20min, 10,000 g for 
30min and 100,000 g for 2hrs all at 4oC in a Microfuge 20R (Beckman Coulter) and an 
Optima L-90K Utracentrifuge (Beckman Coulter). For density gradient flotation 
experiments, the 100,000 g pellet was collected in a 60% sucrose solution followed by 
layering of 40% and 20% sucrose. Samples were spun overnight (16-18hrs) at 150,000 g 
then particles recovered from three fractions by centrifugation at 150,000 g for 1hr. All 
fractions were finally resuspended in PBS.
Nanoparticle tracking and electron microscopy—Nanoparticle tracking as 
performed using a NanoSight LM10 (Malvern Instruments) or a ZetaView (Particle Metrix). 
A serially centrifuged 100,000 g pellet or 40% sucrose float fraction from the BALF of 6 
pooled mice was resuspended in 50 ul of PBS and submitted for negative staining using 
uranyl acetate on copper coated grids and visualized with a JEOL 100CX transmission 
electron microscope (Gladstone Institutes, University of California, San Francisco). The 
fraction of liposome-like and extracellular vesicle-like particles was assessed by manual 
counting. The diameter of the vesicles were determined using ImageJ, RRID:SCR_003070 
(Schneider et al., 2012).
Western blot—Cells and 100,000 g cell pellets were lysed in RIPA buffer (10mM Tris-
HCL, 1mM EDTA, 0.5mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% 
SDS, 140mM NaCl) with 1mM PMSF for 15min on ice. Protein was quantified using a 
Pierce BCA Protein Assay (Thermo Scientific). Lysates were resolved on a 4%–12% BisTris 
Bolt mini gel (Invitrogen) and transferred to nitrocellulose membrane. Membranes were 
blocked with 5% powdered milk or 5% BSA and washed with TBS-T (0.1% Tween-20, 
137mM NaCl, 20mM Tris Base). Primary antibodies were used at manufacturer 
recommended dilutions and included anti-Alix (Abcam, EPR15314 ab186429, RRID: 
AB_2754981), anti-Tsg101 (Abcam, ab30871, RRID: AB_2208084), anti-CD63 (Abcam, 
EPR21151, ab217345, RRID: AB_2754982), anti-Syntenin (Abcam, ab19903, RRID: 
AB_445200), anti-Arf6 (Abcam, ab77581, RRID: AB_2058475), and anti-CD9 (Santa Cruz, 
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KMC8.8, sc-18869, RRID: AB_2076043). Secondary HRP antibodies were goat anti-rabbit 
(Invitrogen, A16110, RRID: AB_2534782) and donkey anti-rat (Invitrogen, A18745, RRID: 
AB_2535522), and blots detected with Pierce ELC Western Substrate (Thermo) or 
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo) on an AI600 imager (GE 
Healthcare). Bands were quantified using ImageJ, RRID:SCR_003070.
EV flow—A Cytoflex Flow Cytometer (Beckman Coulter) was configured according to the 
manufacturer’s instructions for vesicle flow cytometry with the SSC detected using the 
violet 405 laser. BALF and serum samples were diluted in PBS and collected for 2min on 
low or medium speed for a target event rate of ~4,000 events/second (and no more than 
~8,000 events/second) to avoid swarm effects due to coincident particle detection (Figure 
S6). Event collection was thresholded on violet SSC such that average particle counts for 
PBS alone were on average ≥ 400 events/ second (or approximately 10% of the total event 
rate of sample being run).
Immunofluorescent microscopy—Lungs were inflated with 0.75ml of 75% OCT 
(Tissue-Tek) and 2% paraformaldehyde, then placed in a 4% paraformaldehyde solution in 
PBS for 1hr at room temperature. The lungs were washed with 20ml of PBS for 1hr then 
incubated overnight in 30% sucrose in PBS with 0.02% sodium azide. The following day, 
they were incubated for 2hrs with 50% OCT and 15% sucrose in PBS, placed in a cryomold 
with OCT for 1 hour on ice, fixed in dry ice and sectioned on a cryostat. Sections were 
covered by ProLong Gold Antifade reagent (Invitrogen) and imaged on a Zeiss Axio upright 
fluorescent microscope.
QUANTIFICATION AND STATISTICAL ANALYSIS
Excel (Microsoft), Prism (GraphPad), FlowJo (TreeStar) and R Studio (RStudio Team, 
2017) were used for data analysis. Individual statistical tests performed are included in the 
data legends. All data was assumed to be normally distributed.
DATA AND SOFTWARE AVAILABILITY
The accession number for the miRNA sequencing data reported in this paper is GEO: 
GSE121818.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Lung extracellular miRNAs have a composition similar to lung epithelium
• Extracellular vesicles (EVs) in airway fluid contain miRNAs
• Genetic membrane tagging and single vesicle flow identify cell sources of 
EVs in vivo
• Immune extracellular miRNAs and EVs increase during allergic lung 
inflammation
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Figure 1. Ex-miRNAs Are Abundant in BALF and Reflect the Composition of the Local Tissue 
Environment
(A) Schematic of extracellular and cellular specimens collected for miRNA sequencing.
(B) Average percentage of mapped reads by RNA class.
(C) Calibrator-calculated amount of miRNAs per total input RNA for each specimen type (n 
= 6–14, 1-way ANOVA with Tukey’s multiple comparison test).
(D) Calibrator-calculated molecules of miRNA per input volume of biofluids (n = 14, 
unpaired t test).
(E) Cumulative distribution frequency of reads for top 100 expressed miRNAs for each 
sample type.
(F) Principle component analysis of the 100 most variant miRNAs in sequenced samples.
(G) Heatmap of calibrator-calculated miRNA amount per total input RNA for top 50 
expressed miRNAs from each sample type. Clustering of sample types was supervised and 
clustering of miRNAs was unsupervised.
Error bars are mean + SD; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
See also Figures S1, S2, and S3 and Table S1.
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Figure 2. Ex-miRNA Are Stable and Protected from RNases in BALF
(A) qPCR of synthetic miRNAs (“calibrators” Cal1 and Cal2) spiked into Trizol or BALF 
with or without an RNase inhibitor (RNAsin) (n = 3 from 1–2 independent experiments, 1-
way ANOVA with Bonferroni’s multiple comparison test).
(B) qPCR of analysis of miRNAs from BALF and RNA pellets treated with RNaseA (n = 3 
from 3 independent experiments, 2-way ANOVA with Bonferroni’s multiple comparison 
test).
Error bars are mean + SD; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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Figure 3. EVs Are Present in BALF
(A) Concentration of particles in BALF and serum by nanoparticle tracking assays. Each 
data point represents the average of 3 technical replicate readings for a single mouse (n = 4, 
2-tailed t test).
(B) Size distribution of particles in BALF and serum in the same mice as (A); 100 nm beads 
are included as a positive control.
(C) Example transmission electron micrograph of EV-like and liposome-like vesicles 
observed in BALF.
(D) Percentage of morphologically distinct structures in BALF (n > 400 vesicles from 5 
images).
(E) Size distribution of EV-like vesicles identified by transmission electron microscopy 
(TEM) from BALF (n = 96 vesicles).
(F) Western blot analysis and quantification of EV markers after loading 10 μg of cell lysate, 
100,000 g pellet from BALF, and 100,000 g pellet from serum (n = 4 from 2 independent 
experiments).
(G) Western blot analysis after loading 1 × 109 particles from 100,000 g pellets of BALF 
and serum. Data representative of 2 independent experiments.
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Figure 4. Select Ex-miRNAs Are Increased in Lung after the Induction of Allergic Airway 
Inflammation
(A) Schematic of 3 experimental groups sequenced: CTR, IMM, and AA.
(B) Calibrator-calculated amount of miRNA per total input RNA for each specimen type (n 
= 1–7, 2-way ANOVA with Tukey’s multiple comparison test for comparing between CTR, 
IMM, and AA in each specimen type).
(C) Calibrator-calculated molecules of ex-miRNAs per input volume of biofluids (n = 3–7, 
2-way ANOVA with Tukey’s multiple comparison test for comparing between CTR, IMM, 
and AA in each specimen type).
(D and E) MA plots comparing base mean expression of miRNAs across all specimen and 
sample types to log2 fold change of ex-miRNA in BAL in AA versus CTR/IMM (D) or in 
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AA pellet versus AA epithelium (E). Outlined points with underlined miRNAs in (E) were 
significantly upregulated or downregulated in (D) (padj < 0.001).
(F) qPCR for ex-miRNAs and other extracellular small RNAs in 20%, 40%, and 60% 
sucrose fractions after flotation of 100,000 g pellets from BALF isolated from IMM and AA 
mice (n = 5 from 2 independent experiments, 2-way ANOVA with Tukey’s multiple 
comparison test for comparing among fractions and Sidak’s multiple comparison test for 
comparing between IMM and AA in 1 fraction).
Error bars are mean + SD; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. See 
also Tables S2, S3, and S4.
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Figure 5. EV Flow with Conditionally Expressed Membrane Fluorescent Proteins
(A) Flow cytometry of 100–900 nm fluorescent beads. Size is detected by SSC using the 405 
laser (violet SSC) (representative of >10 independent experiments).
(B) Flow cytometry of BALF from wild-type (WT) control, mTmG, and mTmG Actin-Cre 
mice for the detection of EVs positive for membrane-bound Tomato (mTom) and mGFP 
(membrane-bound GFP).
(C and D) mGFP+ vesicle counts (C) and size (D) are also quantified (n = 4–5 from 2–3 
independent experiments, 2-tailed t test).
Error bars are mean + SD; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. See 
also Figures S4 and S6.
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Figure 6. EVs of Hematopoietic Origin Are Increased in Allergic Airway Inflammation
(A) Fluorescence microscopy of lungs from WT, mTmG Nkx2.1-Cre, and mTmG Vav-Cre 
mice.
(B) EV flow of BALF from mTmG Nkx2.1-Cre and mTmG Vav-Cre mice for the detection 
of EVs positive for mTom and mGFP. Relative percentage of mGFP+ among all fluorescent 
positive EVs (mGFP+ and mTom+) is graphed (n = 4 mice from 3 independent experiments, 
1-way ANOVA with Tukey’s multiple comparison test).
(C and D) mGFP+ EV counts (C) and size (D) are also quantified in BALF (n = 4–5 from 3 
independent experiments, 2-tailed t test).
(E) EVs among all fluorescent positive particles in IMM or AA mTmG Nkx2.1-Cre and 
mTmG Vav-Cre mice.
(F and G) Quantification of percentage (F) and fold change (G) in mGFP+ EVs in IMM and 
AA BALF. Fold change is normalized to IMM average in each experiment (n = 7–9 mice 
from 4 independent experiments, 1-way ANOVA with comparing IMM versus AA with 
Bonferroni’s multiple comparison test).
Error bars are mean + SD; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. See 
also Figures S4 and S5.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit monoclonal anti-Alix [EPR15314] N-terminal Abcam Cat# ab186429; RRID:AB_2754981
Rabbit polyclonal anti-Tsg101 Abcam Cat# ab30871; RRID:AB_2208084
Rabbit monoclonal anti-CD63 [EPR21151] Abcam Cat# ab217345; RRID:AB_2754982
Rabbit polyclonal anti-Syntenin Abcam Cat# ab19903; RRID:AB_445200
Rabbit polyclonal anti-Arf6 Abcam Cat# ab77581; RRID:AB_2058475
Rat monoclonal anti-CD9 (KMC8.8) Santa Cruz Cat# sc-18869; RRID:AB_2076043
Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary 
Antibody, HRP
Invitrogen Cat# A16110; RRID:AB_2534782
Donkey anti-Rat IgG (H+L) Highly Cross-Adsorbed Secondary 
Antibody, HRP
Invitrogen Cat# A18745; RRID:AB_2535522
Chemicals, Peptides, and Recombinant Proteins
BD Microtainer SST Becton Dickinson Cat# 365967
Imject Alum Thermo Scientific Cat# 77161
Ovalbumin Sigma-Aldrich Cat# A5503; CAS Number 9006-59-1
Phusion High-Fidelity DNA Polymerase New England Biolabs Cat# M0530
RNase A Thermo Scientific Cat# EN0531
RNasin Promega Cat# N2511
Roche FastStart Universal SYBR Green Master mix (Rox) Sigma-Aldrich Cat# 04913850001
TRIzol Invitrogen Cat# 15596018
TRIzol LS Invitrogen Cat# 10296028
Critical Commercial Assays
DNA Adenylation Kit New England BioLabs Cat# E2610
miR-X First Strand Synthesis Kit Clonetech Cat# 638315
Pierce BCA Protein Assay Kit Thermo Scientific Cat# 23227
RNA 6000 Pico Kit Agilent Cat# 5067-1513
Deposited Data
miRNA sequencing data GEO GSE121818
Experimental Models: Organisms/Strains
Mouse: Actin-cre (B6N.FVB-Tmem163Tg(ACTB-cre)2Mrt/CjDswJ) The Jackson Laboratory RRID:IMSR_JAX:019099
Mouse: mTmG (B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J) The Jackson Laboratory RRID:IMSR_JAX:007676
Mouse: Nkx2.1-cre (C57BL/6J-Tg(Nkx2-1-cre)2Sand/J) The Jackson Laboratory RRID:IMSR_JAX:008661
Mouse: Vav-cre (B6.Cg-Commd10Tg(Vav1-icre)A2Kio/J) The Jackson Laboratory RRID:IMSR_JAX:008610
Mouse: Wild type (C57BL/6J) NCI Mouse Repository Cat# 01B96
Oligonucleotides
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REAGENT or RESOURCE SOURCE IDENTIFIER
See Table S5 N/A
Software and Algorithms
cutadapt Martin, 2011 https://cutadapt.readthedocs.io/en/stable/installation.html
DESeq2 Love et al., 2014 https://www.bioconductor.org/packages/release/bioc/html/DESeq2.html
DREAM Bailey, 2011 http://meme-suite.org/doc/dreme.html
exceRpt small RNA-seq Pipeline v4 Bioinformatics 
Research Laboratory, 
Baylor College of 
Medicine
http://www.genboree.org/site/
FastX Toolkit Cold Spring Harbor 
Laboratory
http://hannonlab.cshl.edu/fastx_toolkit/index.html
FlowJo v9 and v10 TreeStar FlowJo, RRID:SCR_008520; https://www.flowjo.com/solutions/flowjo
ImageJ Schneider et al., 2012 ImageJ, RRID:SCR_003070; https://imagej.net/Welcome
Improbizer University of 
California, Santa Cruz
https://users.soe.ucsc.edu/~kent/improbizer/improbizer.html
Prism 7 GraphPad Software GraphPad Prism, RRID:SCR_002798; https://www.graphpad.com/
R Studio RStudio Team, 2017 https://www.rstudio.com
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